Troxipide in the Management of Gastritis: A Randomized Comparative Trial in General Practice

Table 2

Mean four-point scale (FPS) scores for signs of endoscopic Gastritis in patients at baseline and week 4.

	Troxipide; mean VAS score (±SD)	Ranitidine; mean VAS score (±SD)	𝑃 values for difference between treatments
Gastric Mucosal Erosion
Baseline	2.58±0.95	2.17±0.84
Week 4	1.08±0.33^∗	1.39±0.57^∗	<.01
Gastric mucosal Oozing
Baseline	1.55±0.71	1.31±0.55
Week 4	1.01±0.21^∗	1.06±0.23^∗	<.05
Gastric mucosal Redness
Baseline	2.73±0.72	2.45±0.79
Week 4	1.28±0.48^∗	1.65±0.63^∗	<.05
Gastric mucosal Edema
Baseline	2.10 ± 0.91	1.87±0.84
Week 4	1.04±0.26^∗	1.32±0.53^∗	<0.05

^∗𝑃 Value less than  .05 versus baseline, within the group.